Advanced Alzheimer's: Bryostatin-1 may be safe, effective

A phase 2 clinical trial conducted by industry developers suggests that Bryostatin-1 may be safe and promising in the treatment of advanced Alzheiemer's disease

Related Keywords

Alan Tuchman ,Santa Monica ,Clifford Segil ,Providence Saint John Health Center ,Mini Mental Status Exam ,Medical News Today ,Providence Saint John ,Health Center ,Alzheimer X27s Disease ,